Hormone Replacement Therapy

Hormone Replacement Therapy - most related articles:

- Combined hormone therapy increases lobular breast cancer risk - 6.1
- Cancer risk found for long-term hormone therapy - 5.8
- HRT-breast cancer risk stays same regardless of family history - 5.2
- Hormone therapy at menopause may lead to breast cancer - 5.2
- Hormone replacement therapy increases breast cancer recurrence - 5.1
- Transcatheter aortic valve replacement TAVR shows superiority in heart patients - 5
- Combined hormone therapy makes breast cancer detection difficult - 4.6
- No increased risk of heart attacks in users of HRT - 4.6
- Hormone therapy may increase ovarian cancer risk - 4.5
- Electronic cigarette not a safe or proven quitting method for smokers - 4.3

Hormone Replacement Therapy articles

Moderate weight loss reduces breast cancer risk
Even a moderate amount of weight loss can significantly reduce levels of circulating estrogens that are associated with an increased risk of breast cancer, revealed by researchers at Fred Hutchinson Cancer Research Center.

HRT-breast cancer risk stays same regardless of family history
The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history, a University of Rochester Medical Center study concluded.

No increased risk of heart attacks in users of HRT
It's not what you take but the way that you take it that can produce different results in women who take hormone replacement therapy (HRT), according to new research on the association between HRT and heart attacks, published online in Europe's leading cardiology journal, the European Heart Journal.

Oral HRT doubles risk of blood clots
Hormone replacement therapy (HRT) given in skin patches may cause fewer blood clots than HRT given orally, revealed by researchers in British Medical Journal, UK. Women who take the oral form of HRT more than double their risk of developing a blood clot.

Hormone replacement therapy increases breast cancer recurrence
A new study HABITS revealed that breast cancer survivors who took hormone replacement therapy (HRT) for peri- and postmenopausal symptoms increases disease recurrence than those who did not take HRT.

Oral contraceptive pills can protect against ovarian cancer
Use of oral contraceptives during a woman's life-time gives substantial long-term protection against ovarian cancer and the longer they are used, the greater the reduction in risk. These are the conclusions of authors of an Article in this week's edition of The Lancet - a medical journal in the United Kingdom.

Combined hormone therapy increases lobular breast cancer risk
Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers.

7 Hormone Replacement Therapy articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
3.79